Mass cytometry Pharmacology Interstitial lung disease Cytokines Case reports Autoimmunity Adult Anti-IgE IgG AAV humoral immunity Anti-MDA5 autoantibodies COVID-19 Fabry disease Prognosis Inflammation Biomarkers IBM Antisynthétase Antibodies Gene therapy Aldosterone Adeno-associated virus Cancer Biomarker Adeno-associated vector Inflammatory myopathy Acute Kidney Injury/epidemiology/etiology Assisted communication devices Systems biology AAV Anémie hémolytique Machine learning Humans Skeletal muscle Anticorps anti-agalsidase Amyotrophy Polymyositis AAV antibody Male Antibody responses DM Aged Abnormal movement Multidisciplinarity Anti-agalsidase antibodies Active Anti-interleukin-6 Immunotherapy Inborn errors of metabolism AAV vector Adeno-associated virus vector AAV vectors Myopathy Data integration Female Adverse drug reactions Myositis Bioelectrical impedance analysis Antisynthetase Agalsidase Immune checkpoint inhibitors Acid-alpha-glucosidase Antiphospholipid syndrome Anti-drug antibodies Myocarditis Adjudication Anti-synthetase syndrome Dermatomyositis Interferon Arthritis Anti-Mi2 Sphingosine-1-phosphate B-lymphocyte Auto-antibodies Antisynthetase syndrome Dependovirus/genetics/immunology Amyotrophic lateral sclerosis Auto-immunité Autoimmune diseases Analyses multidimensionnelles Aldostérone Biopsy Animals Adolescence Anti‐mitochondrial antibodies Anticorps spécifique des myosites Biomarqueurs Deep immune profiling Myositis and muscle disease Outcome measures Muscle Auto‐antibodies B cell homeostasis Middle Aged Inclusion body myositis IMNM Autoantibody Cardio-oncology Autoantibodies Idiopathic inflammatory myopathies Lysosomal storage diseases